Requirement for, promotion, or inhibition by α-tocopherol of radical- induced initiation of plasma lipoprotein lipid peroxidation

Free Radical Biology and Medicine

Volumn 22, Issue 1-2, 1997, Pages 57-71

  Neužil, Jiří ^a   Thomas, Shane R ^a   Stocker, Roland ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Atherosclerosis; Free radical; Lipid peroxidation; Lipoxygenase; Low density lipoprotein; Tocopherol mediated peroxidation; Vitamin E; Tocopheroxyl radical

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONATE 15 LIPOXYGENASE; BILIRUBIN; CHOLESTEROL ESTER; COPPER ION; FREE RADICAL; HIGH DENSITY LIPOPROTEIN; HORSERADISH PEROXIDASE; HYDROPEROXIDE; HYDROXYL RADICAL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; URATE; OXIDIZING AGENT; PERHYDROXYL RADICAL; PEROXIDE;

ADULT; ARTICLE; HUMAN; LIPID PEROXIDATION; MALE; NORMAL HUMAN; OXIDATION; PLASMA; PRIORITY JOURNAL; ALPHA TOCOPHEROL DEFICIENCY; BLOOD; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ARMORACIA RUSTICANA; GLYCINE MAX;

FREE RADICALS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS; LIPOPROTEINS, LDL; OXIDANTS; OXIDATION-REDUCTION; PEROXIDES; VITAMIN E; VITAMIN E DEFICIENCY;

EID: 0030641128     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00224-9     Document Type: Article

References (56)

1. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
2. Steinbrecher U. P., Lougheed M., Kwan W.-C., Dirks M. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem. 264:1989;15216-15223.
3. Goldstein J. L., Ho Y. K., Basu S. K., Brown M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:1979;333-337.
4. Nicholson A. C., Frieda S., Pearce A., Silverstein R. L. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler. Thromb. Vasc. Biol. 15:1995;269-275.
5. Steinbrecher U. P., Zhang H., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic. Biol. Med. 9:1990;155-168.
6. Esterbauer H., Gebicki J., Puhl H., Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
7. Burton G. W., Ingold K. U. Vitamin E: Application of the principles of physical organic chemistry to the exploration of its structure and function. Acc. Chem. Res. 19:1986;194-201.
8. Dieber-Rotheneder M., Puhl H., Waeg G., Striegl G., Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J. Lipid Res. 32:1991;1325-1332.
9. Princen H. M., van Poppel G., Vogelezang C., Buytenhek R., Kok F. J. Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler. Thromb. 12:1992;554-562.
10. Jialal I., Grundy S. M. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J. Lipid Res. 33:1992;899-906.
11. Reaven P. D., Witztum J. L. Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha-tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility to oxidation. Arterioscler. Thromb. 13:1993;601-608.
12. Frei B., Gaziano J. M. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J. Lipid Res. 34:1993;2135-2145.
13. Kleinveld H. A., Naber A. H. J., Stalenhoef A. F. H., Demacker P. N. M. Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: Studies in vitamin E deficient subjects. Free Radic. Biol. Med. 15:1993;273-280.
14. Kontush A., Hübner C., Finckh B., Kohlschütter A., Beisiegel U. Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid content. FEBS Lett. 341:1994;69-73.
15. Sato K., Niki E., Shimasaki H. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch. Biochem. Biophys. 279:1990;402-405.
16. Stocker R., Bowry V. W., Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α -tocopherol. Proc. Natl. Acad. Sci. USA. 88:1991;1646-1650.
17. Bowry V. W., Ingold K. U., Stocker R. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem. J. 288:1992;341-344.
18. Ingold K. U., Bowry V. W., Stocker R., Walling C. Autoxidation of lipids and antioxidation by α -tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids. The unrecognized consequences of lipid particle size as examplified by the oxidation of human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 90:1993;45-49.
19. Bowry V. W., Stocker R. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc. 115:1993;6029-6040.
20. Maiorino M., Zamburlini A., Roveri A., Ursini F. Prooxidant role of vitamin E in copper induced lipid peroxidation. FEBS Lett. 330:1993;174-176.
21. Santanam N., Parthasarathy S. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases. J. Clin. Invest. 95:1995;2594-2600.
22. Bowry V. W., Mohr D., Cleary J., Stocker R. Prevention of tocopherol-mediated peroxidation of ubiquinol-10-free human low density lipoprotein. J. Biol. Chem. 270:1995;5756-5763.
23. Neuzil J., Stocker R. Free and albumin-bound bilirubin is an efficient co-antioxidant for α -tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269:1994;16712-16719.
24. Stocker R. Lipoprotein oxidation: Mechanistic aspects, methodological approaches and clinical relevance. Curr. Opin. Lipidol. 5:1994;422-433.
25. Buettner G. R. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: Ascorbate as a test for catalytic metals. J. Biochem. Biophys. Methods. 16:1988;27-40.
26. Sattler W., Mohr D., Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence. Methods Enzymol. 233:1994;469-489.
27. Sattler W., Maiorino M., Stocker R. Reduction of HDL- and LDL-associated cholesterylester- and phospholipid hydroperoxides by phospholipid hydroperoxide glutathione peroxidase and Ebselen (PZ 51). Arch. Biochem. Biophys. 309:1994;214-221.
28. Kritharides L., Jessup W., Gifford J., Dean R. T. A method for defining the stages of LDL oxidation by the separation of cholesterol and cholesteryl ester oxidation products by HPLC. Anal. Biochem. 213:1993;79-89.
29. Esterbauer H., Dieber-Rotheneder M., Striegl G., Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am. J. Clin. Nutr. 53:1991;314S-321S.
30. Traber M. G., Sokol R. J., Burton G. W., Ingold K. U., Papas A. M., Huffaker J. E., Kayden H. J. Impaired ability of patients with familial isolated vitamin E deficiency to incorporate α -tocopherol. J. Clin. Invest. 85:1990;397-407.
31. Traber M. G., Sokol R. J., Kohlschutter A., Yokota T., Muller D. P., Dufour R., Kayden H. J. Impaired discrimination between stereoisomers of alpha-tocopherol in patients with familial isolated vitamin E deficiency. J. Lipid Res. 34:1993;201-210.
32. Rumsey S. C., Stucchi A. F., Nicolosi R. J., Ginsberg H. N., Ramakrishnan R., Deckelbaum R. J. Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys. J. Lipid Res. 35:1994;1592-1598.
33. Niki E., Saito M., Yoshikawa Y., Yamamoto Y., Kamiya Y. Oxidation of lipids. XII. Inhibition of oxidation of soybean phosphatidylcholine and methyl linoleate in aqueous dispersion by uric acid. Bull. Chem. Soc. Jpn. 59:1986;471-477.
34. Niki E., Saito T., Kawakami A., Kamiya Y. Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C. J. Biol. Chem. 259:1984;4177-4182.
35. Yamamoto Y., Brodsky M. H., Baker J. C., Ames B. N. Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography. Anal. Biochem. 160:1987;7-13.
36. Behrens W. A., Madere R. A highly sensitive high-performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in tissues, biological fluids, and foods. Anal. Biochem. 165:1987;102-107.
37. Wayner D. D. M., Burton G. M., Ingold K. U., Barclay L. R. C., Locke S. J. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim. Biophys. Acta. 924:1987;408-419.
38. Stocker R., McDonagh A. F., Glazer A. N., Ames B. N. Antioxidant activities of bile pigments: Biliverdin and bilirubin. Methods Enzymol. 186:1990;301-309.
39. Bowry V. W., Stanley K. K., Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in fasted human plasma. Proc. Natl. Acad. Sci. USA. 89:1992;10316-10320.
40. Thomas S. R., Neuzil J., Stocker R. Co-supplementation with coenzyme Q prevents the pro-oxidant effect of α -tocopherol and increases the resistance of low-density lipoprotein towards transition metal-dependent oxidation initiation. Arterioscl. Thromb. Vasc. Biol. 16:1996;687-696.
41. Frei B., Stocker R., Ames B. N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 85:1988;9748-9752.
42. Kayden H. J., Traber M. G. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res. 34:1993;343-358.
43. Yoshida Y., Tsuchiya J., Niki E. Interaction of α -tocopherol with copper and its effect on lipid peroxidation. Biochim. Biophys. Acta. 1200:1994;85-92.
44. Lynch S. M., Frei B. Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implication for metal ion-dependent oxidative modification of LDL. J. Biol. Chem. 270:1995;5158-5163.
45. 31P NMR study. Biochemistry. 29:1990;3973-3981.
46. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6:1989;67-75.
47. Witting P. K., Bowry V. W., Stocker R. Inverse deuterium kinetic isotope effect for peroxidation in human low-density lipoprotein (LDL): A simple test for tocopherol-mediated peroxidation of LDL lipids. FEBS Lett. 375:1995;45-49.
48. Ylä-Herttuala S., Rosenfeld M. E., Parthasarathy S., Glass C. K., Sigal E., Witztum J. L., Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87:1990;6959-6963.
49. Kühn H., Belkner J., Zaiss S., Fahrenklemper T., Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179:1994;1903-1911.
50. Ylä-Herttuala S., Luoma J., Viita H., Hiltunen T., Sisto T., Nikkari T. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J. Clin. Invest. 95:1995;2692-2698.
51. Boyington J. C., Gaffney B. J., Amzel L. M. The three-dimensional structure of an arachidonic acid 15-lipoxygenase. Science. 260:1993;1482-1486.
52. Kühn H., Belkner J., Suzuki H., Yamamoto S. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J. Lipid Res. 35:1994;1749-1759.
53. Upston, J. M.; Neuzil, J.; Stocker, R. 15-Lipoxygenase requires α -tocopherol to oxidise human low-density lipoprotein's surface and core lipids. Ann. Meeting of the Oxygen Society, Pasadena, CA; 1955:106 (abstract).
54. Suarna C., Dean R. T., May J., Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α -tocopherol and ascorbate. Arterioscler. Thromb. Vasc. Biol. 15:1995;1616-1624.
55. Stocker R., Frei B. Endogenous antioxidant defenses in human blood plasma. Sies H. Oxidative stress: Oxidants and antioxidants. 1991;213-243 Academic Press, London.
56. Kontush A., Meyer S., Finckh B., Kohlschütter A., Beisiegel U. α -Tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation. J. Biol. Chem. 271:1996;11106-11112.